Profile

New User

New to Graphy Publications? Create an account to get started today.

Registered Users

Have an account? Sign in now.

How to Cite | Author Information | Publication History
International Journal of Gastroenterology Disorders & Therapy Volume 4 (2017), Article ID 4:IJGDT-127, 2 pages
https://doi.org/10.15344/2393-8498/2017/127
Commentary
Pancreatic Cancer Screening: Time for New Markers?

Maddalena Zippi

Unit of Gastroenterology and Digestive Endoscopy, Sandro Pertini Hospital, Rome, Italy
Dr. Maddalena Zippi, Unit of Gastronterology and Digestive Endoscopy, Sandro Pertini, Hospital, Via dei Monti Tiburtini 385, 00157, Rome, Italy; E-mail: maddyzip@yahoo.it
25 January 2017; 25 April 2017; 27 April 2017
Zippi M (2017) Pancreatic Cancer Screening: Time for New Markers?. Int J Gastroenterol Disord Ther 4: 127. doi: http://dx.doi.org/10.15344/2393-8498/2017/127
© 2017 Zippi. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

References

  1. Ferlay J, Partensky C, Bray F (2016) More deaths from pancreatic cancer than breast cancer in the EU by 2017. Acta Oncol 55: 1158-1160. View
  2. Benson AB (2007) Adjuvant therapy for pancreatic cancer: one small step forward. JAMA 297: 311-313. View
  3. Duffy MJ, Sturgeon C, Lamerz R, Haglund C, Holubec VL, et al. (2010) Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report. Ann Oncol 21: 441-447. View
  4. Klapdor R, Aronsson AC, Duffy MJ (1999) Tumor markers in gastrointestinal cancers, EGTM recommendations. Anticancer Res 19: 2785-2820.
  5. Tobi M, Maliakkal BJ, Alousi MA, Voruganti V, Shafiuddin M, et al. (1992) Cellular distribution of a colinc adenoma-associated antigen as a defined by monoclonal antibody Adnab-9. Scand J Gastroenterol 27: 737-742.
  6. Tobi M, Cats A, Maliakkal BJ, Kinzie JL, Maliakkal R, et al. (1997) Zollinger-Ellison syndrome, acromegaly, and colorectal neoplasia. J Clin Gastroenterol 24: 21-24. View
  7. Tobi M, Kaila V, Goo R, (1992) An adenoma-associated antigena as a precolonoscopic marker in familial polyposis coli versus sporadic colonic neoplasia. Gastroenterology 102: A403.
  8. Tobi M, Elitsur Y, Moyer MP, Halline A, Deutsch M, et al. (1993) Mucosal origin and shedding of an early colonic tumor marker defined by Adnab-9 monoclonal antibody. Scand JGastroenterol 28: 1025-1034. View
  9. Yuan M, Xhang X, Liu Y, Tobi M (1996) Sensitivity of fecal Adnab-9 testing for colorectal neoplasia. Gastroenterology 110: A619
  10. Tobi M1, Hatfield J, Adsay V, Galagan K, Kozarek R, et al. (2001) Prognostic significance of the labeling of Adnab-9 in pancreatic intraductal papillary mucinous neoplasms. Int J Pancreatol 29: 141-150.
  11. Tobi M, Kim M, Weinstein DH, Rambus MA, Hatfield J, et al. (2013) Prospective markers for early diagnosis and prognosis of sporadic pancreatic ductal adenocarcinoma. Dig Dis Sci 58: 744-750. View
  12. Mayers JR, Wu C, Clish CB, Kraft P, Torrence ME, et al (2014) Elevated circulating branched chain amino acids are an early event in pancreatic adenocarcinoma development. Nat Med 20: 1193-1198. View
Best viewed in Mozilla Firefox, Google Chrome, Safari, Above IE 9.0 version
Privacy Policy | Copyright & Permissions
Copyright © 2013-2024 Graphy Publications, All Rights Reserved.